Literature DB >> 19267994

The questionable association of vitamin E supplementation and mortality--inconsistent results of different meta-analytic approaches.

J Gerss1, W Köpcke.   

Abstract

Medical research suggests benefits of vitamin E supplementation in treatment or prevention of cardiovascular disease, inflammatory joint diseases and cancer. Regardless of these benefits in a recently published meta analysis the authors drew the conclusion that high dose supplementation may cause a slight increase in mortality of the treated patients. The purpose of the present paper is to re-analyse the association of vitamin E supplementation and mortality. By means of augmented data sources as well as additional methodological approaches the results of the above mentioned meta analysis is to be either confirmed or called into question. In the above mentioned meta analysis 19 clinical trials comprising a total of 135967 participants were included. The dosages of vitamin E supplementation ranged from 16.5 to 2000 IU/d. In the present paper this data source was augmented and 10 additional trials were included (2495 additional participants receiving vitamin E doses from 136 to 5000 IU/d). Moreover in 2 of the originally included trials updated results of mortality at longer periods of follow-up were available. The present paper yields contradictory results regarding the association of vitamin E supplementation and mortality. Hierarchical logistic regression analyses confirm the former results showing an increased mortality of patients receiving high dose vitamin E. Furthermore a traditional methodological approach of meta-regression was applied to the same data source. Contrary to the former result it showed that the increased mortality odds ratio in certain trials is not due to the higher dose of vitamin E supplementation. Rather it can be explained by a higher proportion of male patients that were included in these trials compared to other trials. The causal relationship of vitamin E supplementation and increased mortality is questionable. Different methodological approaches of meta analysis yield contradictory results. Thus none of these results can be regarded to supply evidence in a statistical sense. In particular high dose vitamin E supplementation can not be regarded proved to increase mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267994

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  24 in total

Review 1.  Current management of non-alcoholic steatohepatitis.

Authors:  Mark D Muthiah; Arun J Sanyal
Journal:  Liver Int       Date:  2020-02       Impact factor: 5.828

Review 2.  Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?

Authors:  Bülent Baran; Filiz Akyüz
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

3.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 4.  Pharmacotherapy for Nonalcoholic Fatty Liver Disease.

Authors:  Samer Gawrieh; Naga Chalasani
Journal:  Semin Liver Dis       Date:  2015-09-17       Impact factor: 6.115

Review 5.  Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.

Authors:  Juan P Arab; Roberto Candia; Rodrigo Zapata; Cristián Muñoz; Juan P Arancibia; Jaime Poniachik; Alejandro Soza; Francisco Fuster; Javier Brahm; Edgar Sanhueza; Jorge Contreras; M Carolina Cuellar; Marco Arrese; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

6.  Randomised vitamin E supplementation and risk of chronic lung disease in the Women's Health Study.

Authors:  Anne H Agler; Tobias Kurth; J Michael Gaziano; Julie E Buring; Patricia A Cassano
Journal:  Thorax       Date:  2011-01-21       Impact factor: 9.139

Review 7.  Vitamin E and nonalcoholic fatty liver disease.

Authors:  Tommy Pacana; Arun J Sanyal
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-11       Impact factor: 4.294

Review 8.  Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Authors:  Gábor Firneisz
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

9.  Practice patterns in NAFLD and NASH: real life differs from published guidelines.

Authors:  Mary E Rinella; Zurabi Lominadze; Rohit Loomba; Michael Charlton; Brent A Neuschwander-Tetri; Stephen H Caldwell; Kris Kowdley; Stephen A Harrison
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

Review 10.  Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.

Authors:  Licia Polimeni; Maria Del Ben; Francesco Baratta; Ludovica Perri; Fabiana Albanese; Daniele Pastori; Francesco Violi; Francesco Angelico
Journal:  World J Hepatol       Date:  2015-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.